Cargando…
Efficacy and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis: meta-analysis of randomized clinical trials
INTRODUCTION: Calcineurin inhibitors, novel topical immunomodulators, may constitute a superior alternative for glucocorticosteroids in atopic dermatitis (AD) topical treatment. AIM: Determination of efficacy and safety of each topical calcineurin inhibitor (TCI) formulation, 0.3% or 0.1% tacrolimus...
Autores principales: | £abędź, Natalia, Pawliczak, Rafał |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986278/ https://www.ncbi.nlm.nih.gov/pubmed/31998006 http://dx.doi.org/10.5114/ada.2019.91425 |
Ejemplares similares
-
Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations
por: Carr, Warner W.
Publicado: (2013) -
CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults
por: Segal, Audrey O, et al.
Publicado: (2013) -
Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis
por: Siegfried, Elaine C., et al.
Publicado: (2016) -
Reflectance Confocal Microscopy in Monitoring Atopic Dermatitis Treated with Topical Calcineurin Inhibitors
por: Bratu, Dalia, et al.
Publicado: (2023) -
Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis
por: Alves, Carlos, et al.
Publicado: (2023)